$5.01
-0.06[-1.18%]
At close: May 17
$5.01
0[0.00%]
After Hours: 4:00PM EDT
uniQure
(NASDAQ:QURE)Latest News for uniQure Stock (NASDAQ:QURE)
uniQure Stock (NASDAQ: QURE)
Categories: All
Wednesday, May 08, 2024
Monday, March 04, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
Wednesday, February 28, 2024
Tuesday, January 16, 2024
Wednesday, December 20, 2023
Tuesday, December 19, 2023
- Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Dec 19, 2023, 1:34PM
- uniQure shares are trading lower after the company announced updated interim data on the Phase I/II clinical trials of AMT-130 for the treatment of Huntington's disease. Also, Mizuho downgraded the stock from Buy to Neutral and announced a $10 price target.Benzinga Newsdesk - Dec 19, 2023, 12:47PM
- Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On TuesdayAvi Kapoor - Dec 19, 2023, 10:19AM
- uniQure Announces Updated Interim Data On Phase I/II Clinical Trials Of AMT-130 Gene Therapy For The Treatment Of Huntington's DiseaseBenzinga Newsdesk - Dec 19, 2023, 7:13AM
- Mizuho Downgrades uniQure to Neutral, Announces $10 Price TargetBenzinga Newsdesk - Dec 19, 2023, 4:16AM
Thursday, December 14, 2023
Tuesday, December 12, 2023
Wednesday, November 29, 2023
Wednesday, November 08, 2023
Thursday, October 05, 2023
- Gene Therapy Player UniQure To Lay Off 20% Of Workforce, Stop Parkinson's StudyVandana Singh - Oct 5, 2023, 10:23AM
- Uniqure Shares Resumed Trading Higher After Co Announced Strategic ReorganizationCharles Gross - Oct 5, 2023, 7:42AM
- uniQure Plans Discontinuing Investments In More Than Half Of Research And Technology Projects; Chief Scientific Officer Ricardo Dolmetsch To Depart CompanyBenzinga Newsdesk - Oct 5, 2023, 7:12AM
- uniQure NV Shares To Resume Trade At 7:35 AM ETCharles Gross - Oct 5, 2023, 7:12AM
- uniQure Plans Reduction Of 28% Of Workforce Not Related To HEMGENIX Manufacturing Obligations; Total Cost Savings Of $180M To Extend Cash Runway Into Q2 Of 2027Benzinga Newsdesk - Oct 5, 2023, 7:11AM
- uniQure Plans Strategic Reorganization To Cut Operating Expenses And Support Advancement Of Multiple Clinical-Stage ProgramsBenzinga Newsdesk - Oct 5, 2023, 7:09AM
Tuesday, October 03, 2023
Monday, October 02, 2023
Thursday, September 28, 2023
Tuesday, September 19, 2023
Tuesday, September 05, 2023
- Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 5, 2023, 1:34PM
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Sep 5, 2023, 1:34PM
- uniQure Wins FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe EpilepsyBenzinga Newsdesk - Sep 5, 2023, 7:06AM
Monday, August 14, 2023
Wednesday, August 09, 2023
Wednesday, August 02, 2023
- HC Wainwright & Co. Maintains Buy on uniQure, Lowers Price Target to $30Benzinga Newsdesk - Aug 2, 2023, 12:28PM
- RBC Capital Maintains Outperform on uniQure, Lowers Price Target to $42Benzinga Newsdesk - Aug 2, 2023, 11:58AM
- Analyst Expectations for uniQure's FutureBenzinga Insights - Aug 2, 2023, 9:00AM
- Raymond James Maintains Outperform on uniQure, Lowers Price Target to $50Benzinga Newsdesk - Aug 2, 2023, 7:43AM
Thursday, July 27, 2023
Wednesday, July 26, 2023
Tuesday, July 25, 2023
Monday, July 24, 2023
Friday, July 21, 2023
Thursday, July 20, 2023
Thursday, June 22, 2023
- Chardan Capital Maintains Buy Rating for uniQure: Here's What You Need To KnowBenzinga Insights - Jun 22, 2023, 1:01PM
- Nordson To Rally Over 14%? Here Are 10 Other Analyst Forecasts For ThursdayLisa Levin - Jun 22, 2023, 7:43AM
- Chardan Capital Maintains Buy on uniQure, Lowers Price Target to $27Benzinga Newsdesk - Jun 22, 2023, 4:12AM